ANI Pharmaceuticals ANIP Q1 2025 earnings
Reported May 9, 2025 · Before market open
Revenue$197.1MBeat by $8.4M
EPS$1.70Beat by $0.33
Revenue estimate$188.7M
EPS estimate$1.37
Next report
Aug 7, 2026 (In 1 week)Revenue estimate$260.1M
EPS estimate$2.01
Financials
Q1 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment ANI Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did ANI Pharmaceuticals report Q1 2025 earnings?
- ANI Pharmaceuticals (ANIP) reported Q1 2025 earnings on May 9, 2025 before market open.
- What were ANI Pharmaceuticals's Q1 2025 revenue and EPS?
- ANI Pharmaceuticals reported revenue of $197.1M and eps of $1.70 for Q1 2025.
- Did ANI Pharmaceuticals beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $188.7M by $8.4M. EPS beat the consensus estimate of $1.37 by $0.33.
- How did ANI Pharmaceuticals's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 43.4% from $137.4M a year earlier and eps grew 40.5% from $1.21.
- Where can I find ANI Pharmaceuticals's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001023024-25-000046) directly on SEC EDGAR. The filing index links above go to sec.gov.